Working across the Neuroscience portfolio, which includes assets in neurodegeneration, movement disorders, psychiatry, and migraine, our comprehensive approach includes the discovery and development of novel positron emission tomography (PET) radioligands, as well as the application of PET, magnetic resonance imaging (MRI), and related imaging methods in drug discovery and development. Bachelor’s degree in medical physics, biomedical engineering, computer science, neuroscience, or a related field, with typically 10–12 years of experience; or a master’s degree or equivalent education, with typically 8–10 years of experience; or a PhD, with no experience necessary to typically 4 years of experience, depending on the Senior Scientist level (I or II).